Skip to main content
. 2020 Jul 3;8:553. doi: 10.3389/fbioe.2020.00553

Figure 3.

Figure 3

Validation of the 26LncSigT1DM signature using an additional independent cohort. (A) Performance of different lncRNA numbers in distinguishing healthy and diabetic individuals of the validation cohort. (B) Performance of the SVM and 3-fold cross-validation–based 26LncSigT1DM signature in distinguishing healthy and diabetic individuals of the validation cohort.